drugset / Trial / NCT06537505
A Study of Microwave Ablation Combined With Immunotherapy ± Anti-angiogenic Drugs in the Treatment of Solid Tumors
Non-randomizedParallel-groupOpen-labelTreatment
Summary
This is a multi-center, phase Il trial to evaluate the efficacy and safety of microwave ablation combined with immunotherapy ± anti-angiogenic drugs in the treatment of advanced second-line and above solid tumors.
Timeline
- Start
- 2024-08-05
- Primary completion
- 2027-04-01
- Completion
- 2027-08-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Rivoceranib | Small molecule | — | — |
| Background | Adebrelimab | Monoclonal antibody | — | Intravenous |